This week's sponsor is Premier Research. | | Overcoming Risk in Oncology Drug Development Oncology drug development is fraught with obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. It's what we do. Best. | Today's Rundown AstraZeneca ups oncolytic virus activity with Transgene deal Arcus hires ex-AbbVie, Genentech researcher as CMO Celgene taps Presage's microdosing tech for phase 0 cancer studies [Sponsored] Emerging Biotechs are Here to Stay; CRO Models Will Permanently Change Tmunity boosts pipeline with childhood brain cancer treatment from UCSF Biogen's antisense ALS drug shows promise in early clinical trial Featured Story | Thursday, May 2, 2019 AstraZeneca has teamed up with Transgene to develop oncolytic virus candidates. The Big Pharma is paying $10 million (€9 million) upfront to get Transgene to apply its oncolytic virus expertise and technologies to the development of five assets. |
|
| Top Stories Thursday, May 2, 2019 Arcus Biosciences has named ex-AbbVie and Genentech employee William Grossman as chief medical officer. Grossman joins the immuno-oncology biotech as it gears up for readouts from early-phase trials of its most advanced candidates. Thursday, May 2, 2019 Celgene inked a research deal around Presage’s technology that injects tiny doses of experimental drugs directly into solid tumors. The Big Biotech will use it to evaluate early-stage candidates in phase 0 trials—that's right, phase 0. Monday, April 29, 2019 The prominence of emerging biotech looms large on the drug development landscape. CROs continue to adjust their core competencies and cultural mindset to tailor services for specific biotech needs. Thursday, May 2, 2019 Tmunity Therapeutics has licensed a T-cell receptor treatment from the University of California, San Francisco, for diffuse intrinsic pontine glioma, a rare, fatal childhood brain cancer. It aims to start human trials by 2021. Wednesday, May 1, 2019 In the wake of a major pipeline failure in Alzheimer’s disease, Biogen has turned up positive early results for tofersen (BIIB067), an SOD1-targeting antisense treatment for amyotrophic lateral sclerosis. This week's sponsor is ExL Events. | | | Resources Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Elemental Machines Learn how cloud-connected IoT sensors are transforming operations in leading life science labs. Read our white paper “The Smart Lab”. Presented by: Total Brain Total Brain Announces Personalized Test for Treatment Prediction in Depression with 80% Accuracy. Sponsored by: Veradigm Prescription price transparency technology is here – but is it making a difference? Find out HERE. Sponsored by: Strativity Every life sciences firm talks about patient-centricity, but are you doing what it takes to deliver? Sponsored by: USDM Life Sciences The year’s biggest compliance and technology trends in life sciences. Learn about the latest trends impacting the biotech, medical device and pharmaceutical industries. Sponsored by: Eurofins Discovery Learn how to utilize allosteric modulation to maximize its full potential in drug discovery programs. Download this white paper to learn more. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. BioBasics: Biotech For The Non-Scientist May 8-9, 2019 | New York, NY Drug Development Immersion May 16-17, 2019 | Boston, MA 2019 BIO International Convention June 3-6, 2019 | Philadelphia, PA FierceBiotech Executive Breakfast at BIO 2019 – Getting Real: The Changing Tide on Real-World Evidence in Drug Development June 5, 2019 | Philadelphia, PA World Pharma Week June 17-20, 2019 | Seaport World Trade Center | Boston, MA Medical Sensors Design Conference June 25, 2019 | McEnery Convention Center | San Jose, CA Sensors Expo & Conference June 25-27, 2019 | McEnery Convention Center | San Jose, CA 5th Annual CAR-TCR Summit September 10-13, 2019 | Boston, MA, USA |